Allarity Therapeutics ALLR
NASDAQ ALLR
$0.97 +0.01 (+0.53%)
At close: Sep 29, 2026 · 4:00 PM EDT

Allarity Therapeutics (ALLR) Operating Leases (2020 - 2021)

Updated

Allarity Therapeutics (ALLR) reported Operating Leases of $9,000 for Q4 2021, down 96.6% from $267,000 a year earlier and down 74.3% from the prior quarter.

Analysis

Allarity Therapeutics (ALLR) Operating Leases (2020 - 2021) Analysis & Trends

  • By year, Operating Leases came in at $267,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Allarity Therapeutics 1.56 Mn 1.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 9,000.00
Sep 30, 2021 35,000.00
Dec 31, 2020 267,000.00
API Access

Allarity Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ALLR&period=max&api_key=YOUR_API_KEY